Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 31 July 2008. doi:10.1136/hrt.2008.150847
Heart 2008;94:1361-1363
Copyright © 2008 BMJ Publishing Group Ltd & British Cardiovascular Society

FEATURED EDITORIAL

Genome scanning and cardiovascular disease

Eric J Topol

Professor E J Topol, Scripps Translational Science Institute, Scripps Genomic Medicine, 3344 N Torrey Pines Court, La Jolla 92037, 858-554-5708, California, USA; etopol@scripps.edu

The first 150 words of the full text of this article appear below.

At the end of 2007, Science recognised human genetic variation as the "breakthrough of the year".1 Beginning in April last year and extending through the current year, major advances have been made almost every week to unravel common DNA sequence variants that are incontrovertibly associated with common diseases. More than 50 diseases have now been reported, and many cardiovascular conditions are included in this avalanche of discoveries. There probably has been more progress in understanding the genomics of disease in the past year than for several previous decades in aggregate.


MAJOR INITIATIVES

The seemingly relentless and extraordinary progress in genomics of complex traits is an outgrowth of three major initiatives. First, the Human Genome Project accomplished its goal of sequencing the 3.1 billion base pairs of man, with the draft first announced in 20002 (fig 1). Second, the International HapMap project studied 271 subjects of diverse ancestry3 to break down . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Brautbar, A., Ballantyne, C. M., Lawson, K., Nambi, V., Chambless, L., Folsom, A. R., Willerson, J. T., Boerwinkle, E. (2009). Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Genet 2: 279-285 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.